Empowered Funds
ABVX icon

Empowered Funds’s Abivax ABVX Stock Holding History

Empowered Funds’s Portfolio ABVX Stock Details ABVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$3.25M Buy
+32,782
New +$3.95M 0.01% 990

Other funds holding ABVX

Helikon Investments
Helikon Investments London, United Kingdom $3.52B AUM 36.83% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 42.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Nationale-Nederlanden Powszechne Towarzystwo Emerytalne
Nationale-Nederlanden Powszechne Towarzystwo Emerytalne Warszawa, Poland $2.08B AUM 157.4% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 31.32% 1-Year Est. Return
Two Seas Capital
Two Seas Capital Rye, New York $8.68B AUM 78.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $123B AUM 30.05% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $60.6B AUM 33.98% 1-Year Est. Return

Empowered Funds's ABVX Position: Q3 2026 in Review

Empowered Funds opened a new position in Abivax (ABVX) in Q3 2026: 32,782 shares worth $3.25M. The stake represents 0.01% of the portfolio and ranks #990 among its holdings.

211 funds tracked by Wall St. Rank hold ABVX as of Q3 2026.

  • Empowered Funds held 32,782 shares of Abivax worth $3.25M as of Q3 2026.
  • Abivax was a new Empowered Funds position in Q3 2026.
  • Abivax made up 0.01% of Empowered Funds's portfolio in Q3 2026, its #990 holding.
  • 211 funds tracked by Wall St. Rank held Abivax as of Q3 2026.

Based on Empowered Funds's 13F filing for Q3 2026, filed 13 Nov 2026.